Cargando…

The relationship between neutrophil–lymphocyte ratio and in-stent restenosis in superficial femoral artery

The present study aimed to investigate the relationship between an increase in the pre- and post-operative neutrophil–lymphocyte ratio (NLR) and superficial femoral artery in-stent restenosis (ISR) rate. We recruited 199 patients that underwent superficial femoral artery stenting for lower extremity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yaobo, Ge, Fangfang, Shen, Jing, Song, Jianbo, Xie, Jiapei, Qu, Jiangshuai, Mao, Xinzu, Kuang, Zhaocheng, Wang, Xiang, Wu, Yejun, Wang, Shenghai, Xiao, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Aging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332680/ https://www.ncbi.nlm.nih.gov/pubmed/32583853 http://dx.doi.org/10.1042/BSR20193448

Ejemplares similares

Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018)

Directional Atherectomy for Treating In-Stent Restenosis of the Superficial Femoral Artery
por: Cho, Sungsin, et al.
Publicado: (2020)

In-stent restenosis of superficial femoral artery: use all arrows in the quiver
por: Vadalà, Giuseppe, et al.
Publicado: (2022)

A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume
por: Yang, Yao Bo, et al.
Publicado: (2020)

Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study
por: Miura, Takashi, et al.
Publicado: (2022)

Preprocedural Mean Platelet Volume Level Is a Predictor of In-Stent Restenosis of the Superficial Femoral Artery Stents in Follow-Up
por: Karauzum, Kurtulus, et al.
Publicado: (2018)

In-Stent Restenosis Progression in Human Superficial Femoral Arteries: Dynamics of Lumen Remodeling and Impact of Local Hemodynamics
por: Colombo, Monika, et al.
Publicado: (2021)

Intensive exercise therapy for restenosis after superficial femoral artery stenting: the REASON randomized clinical trial
por: Kato, Tamon, et al.
Publicado: (2022)

Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation
por: Lee, Silvia, et al.
Publicado: (2020)

Predictive value of neutrophil-to-lymphocyte ratio on drug eluting stent restenosis in patients with type 2 diabetes mellitus
por: Wang, Zhi-Chao, et al.
Publicado: (2020)

Prognostic Factors for Restenosis of Superficial Femoral Artery after Endovascular Treatment
por: Boc, Vinko, et al.
Publicado: (2023)

Superficial femoral artery stent extrusion
por: Voruganti, Nihal, et al.
Publicado: (2021)

Stent fractures after superficial femoral artery stenting
por: Park, Jae Young, et al.
Publicado: (2012)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
por: Ott, Ilka, et al.
Publicado: (2017)

Open-Label Multicenter Registry on the Outcomes of In-Stent Restenosis Treated by Balloon Angioplasty with Optical Frequency Domain Imaging in the Superficial Femoral Artery (ISLAND-SFA Study)
por: Yanaka, Kenichi, et al.
Publicado: (2020)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

The neutrophil-to-lymphocyte ratio is associated with mild cognitive impairment in community-dwelling older women aged over 70 years: a population-based cross-sectional study
por: Li, Shengjie, et al.
Publicado: (2023)

Stent fractures in the superficial femoral artery: predisposing factors and their implications
por: Silveira, Fernando Trés, et al.
Publicado: (2022)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Corrigendum: The neutrophil-to-lymphocyte ratio is associated with mild cognitive impairment in community-dwelling older women aged over 70 years: a population-based cross-sectional study
por: Li, Shengjie, et al.
Publicado: (2023)

Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
por: Wang, Hoau-Yan, et al.
Publicado: (2023)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

Effect of Target Lesion Revascularization on Restenosis Lesions of the Superficial Femoral Artery without Recurred Symptoms after Endovascular Therapy
por: Utsunomiya, Makoto, et al.
Publicado: (2021)

Symptomatic superficial femoral artery pseudoaneurysm due to late stent fracture
por: Bilman, Victor, et al.
Publicado: (2020)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Aortoiliac reconstruction in the setting of in-stent restenosis
por: Natraj Setty, H. S., et al.
Publicado: (2017)

Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study
por: Wang, Zhihong, et al.
Publicado: (2022)

Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
por: Litsky, Jason, et al.
Publicado: (2014)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

Subintimal Double-Barrel Restenting of an Occluded Primary Stented Superficial Femoral Artery
por: Duterloo, Dirk, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_4t6g8qb263a07vglfbcc9t619e